Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Warfarin and Antiplatelet Therapy in Chronic Heart Failure

This study has been completed.
Sponsor:
Collaborators:
Sanofi-Synthelabo
Bristol-Myers Squibb
Information provided by:
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00007683
First received: December 29, 2000
Last updated: June 14, 2011
Last verified: June 2011